These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7017068)

  • 1. Antidepressant efficacy of tranylcypromine isomers: a controlled study.
    Moises HW; Beckmann H
    J Neural Transm; 1981; 50(2-4):185-92. PubMed ID: 7017068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.
    Van de Merwe TJ; Pare CM; Glover V; Sandler M
    Mod Probl Pharmacopsychiatry; 1983; 19():189-202. PubMed ID: 6346066
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Adverse Effects of Tranylcypromine and Tricyclic Antidepressants in the Treatment of Depression: A Systematic Review and Comprehensive Meta-analysis.
    Ulrich S; Ricken R; Buspavanich P; Schlattmann P; Adli M
    J Clin Psychopharmacol; 2020; 40(1):63-74. PubMed ID: 31834088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
    Reynolds GP; Riederer P
    Int Pharmacopsychiatry; 1981; 16(1):30-3. PubMed ID: 7298269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient recovery of monoamine oxidase in a bioequivalence study of the monoamine oxidase inhibitor tranylcypromine: Recommendation of the tranylcypromine enantiomer test.
    Ulrich S; Hock D; Guth V; Erenmemisoglu A; Scheidel B
    Int J Clin Pharmacol Ther; 2022 May; 60(5):242-252. PubMed ID: 35279222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of tranylcypromine treatment of major anergic depression.
    Himmelhoch JM; Fuchs CZ; Symons BJ
    J Nerv Ment Dis; 1982 Oct; 170(10):628-34. PubMed ID: 7050302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
    Schiwy W; Heath WR; Delini-Stula A
    J Neural Transm Suppl; 1989; 28():33-44. PubMed ID: 2677240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen therapy for severe persistent depressions in women.
    Klaiber EL; Broverman DM; Vogel W; Kobayashi Y
    Arch Gen Psychiatry; 1979 May; 36(5):550-4. PubMed ID: 219802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranylcypromine in mind (Part I): Review of pharmacology.
    Ulrich S; Ricken R; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.
    Reynolds GP; Riederer P; Sandler M
    J R Soc Med; 1981 Sep; 74(9):649-52. PubMed ID: 7288807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.
    White K; Razani J; Cadow B; Gelfand R; Palmer R; Simpson G; Sloane RB
    Psychopharmacology (Berl); 1984; 82(3):258-62. PubMed ID: 6425910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
    Quitkin F; Rifkin A; Klein DF
    Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 16. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
    Volz HP; Heimann H; Bellaire J; Laux G; Möller HJ
    Pharmacopsychiatry; 1994 Jul; 27(4):152-8. PubMed ID: 7972347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.
    Thase ME; Mallinger AG; McKnight D; Himmelhoch JM
    Am J Psychiatry; 1992 Feb; 149(2):195-8. PubMed ID: 1734739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranylcypromine versus imipramine in anergic bipolar depression.
    Himmelhoch JM; Thase ME; Mallinger AG; Houck P
    Am J Psychiatry; 1991 Jul; 148(7):910-6. PubMed ID: 2053632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lithium-tranylcypromine treatment in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
    Volz HP; Faltus F; Magyar I; Möller HJ
    J Affect Disord; 1994 Mar; 30(3):209-17. PubMed ID: 8006247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.